Onyx Reports Positive Trial Results
Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) reported positive results for its drug candidate that treats patients with advanced breast cancer sending the stock price soaring $6.63 to $35.32.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.